EP 1227831 A2 20020807 - INTERFERON GAMMA FOR THE TREATMENT OF ASTHMA
Title (en)
INTERFERON GAMMA FOR THE TREATMENT OF ASTHMA
Title (de)
GAMMA INTERFERON ZUR BEHANDLUNG VON ASTHMA
Title (fr)
INTERFERON GAMMA POUR LE TRAITEMENT DE L'ASTHME
Publication
Application
Priority
- EP 00976004 A 20001106
- EP 0010941 W 20001106
- EP 99122357 A 19991110
Abstract (en)
[origin: WO0134180A2] The invention describes for the first time the successful clinical application of interferon gamma (IFN- gamma ) in human bronchial asthma therapy. The clinical data show unambiguously that continuous application of IFN- gamma in relatively low doses can be successfully used for long-term treatment of severe asthma bronchiale, especially for glucocorticoid-resistant asthma. The invention relates also to a combination therapy administering IFN- gamma and glucocorticoids, which alone are not or not sufficiently effective in asthma therapy.
IPC 1-7
IPC 8 full level
A61K 31/573 (2006.01); A61K 38/21 (2006.01); A61P 11/06 (2006.01); A61P 29/00 (2006.01)
CPC (source: EP)
A61K 38/217 (2013.01); A61P 11/06 (2017.12); A61P 29/00 (2017.12)
Citation (search report)
See references of WO 0134180A2
Citation (examination)
WO 8707842 A1 19871230 - BIOGEN NV [NL], et al
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0134180 A2 20010517; WO 0134180 A3 20011108; AU 1392301 A 20010606; CA 2387089 A1 20010517; EP 1227831 A2 20020807; JP 2003513933 A 20030415
DOCDB simple family (application)
EP 0010941 W 20001106; AU 1392301 A 20001106; CA 2387089 A 20001106; EP 00976004 A 20001106; JP 2001536177 A 20001106